Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eton PharmaceuticalsETON +44.55%57 Days Inventory is 92.22 as of Jun. 2026, which is 39% below its 10-year median of 150.33. GuruFocus rates ETON with a GF Score™ of 57/100 and a GF Value™ of $19.98 (Significantly Overvalued). The stock has 3 warning signs investors should review. Among 920 Drug Manufacturers companies, Eton Pharmaceuticals ranks better than 53.15% on this metric.
The historical rank and industry rank for Eton Pharmaceuticals's Days Inventory or its related term are showing as below:
ETON'
s Days Inventory Range Over the Past 10 Years
Min: 25.32 Med: 150.33 Max: 678.93
Current: 156.24
During the past 9 years, Eton Pharmaceuticals's highest Days Inventory was 678.93. The lowest was 25.32. And the median was 150.33.
ETON's Days Inventory is ranked better than 53.15% of 920
companies
in the Drug Manufacturers industry
Industry Median: 165.16
vs ETON: 156.24
Eton Pharmaceuticals's Days Inventory
declined
from Jun. 2025 (243.71) to Jun. 2026 (92.22).
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
Eton Pharmaceuticals's Inventory Turnover for the
three
months ended in Jun. 2026 was 0.99.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Eton Pharmaceuticals's Inventory-to-Revenue for the
three
months ended in Jun. 2026 was 0.33.
Eton Pharmaceuticals (NAS:ETON) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
Eton Pharmaceuticals's Inventory Turnover for the
three
months ended in Jun. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
Eton Pharmaceuticals's Inventory to Revenue for the
three
months ended in Jun. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
Eton Pharmaceuticals Days Inventory Related Terms
Eton Pharmaceuticals Days Inventory Historical Data
* Premium members only.
The historical data trend for Eton Pharmaceuticals's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ETON vs COLL, ALVO, PCRX: Days Inventory Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Eton Pharmaceuticals's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eton Pharmaceuticals Days Inventory vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eton Pharmaceuticals's Days Inventory distribution charts can be found below:
* The bar in red indicates where Eton Pharmaceuticals's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eton Pharmaceuticals (ETON) has a Days Inventory of 92.22 as of Jun. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Eton Pharmaceuticals and its competitors. This is 39% below median its historical median of 150.33. Over the past decade, Eton Pharmaceuticals' Days Inventory has ranged from 25.32 to 678.93. According to the industry distribution chart, Eton Pharmaceuticals ranks #431 out of 920 companies in the Drug Manufacturers industry, placing it in the top 46.8%.
Is Eton Pharmaceuticals' Days Inventory too high?
Eton Pharmaceuticals' current Days Inventory of 92.22 is 39% below median its 10-year median of 150.33. Over the past 10 years, this metric has ranged from a low of 25.32 to a high of 678.93. The Drug Manufacturers industry median Days Inventory is 165.16. Eton Pharmaceuticals' value of 92.22 is 44.2% below this industry median. Based on the distribution chart, Eton Pharmaceuticals ranks #431 out of 920 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Eton Pharmaceuticals has a GF Score™ of 57/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Eton Pharmaceuticals' Days Inventory compare to COLL and ALVO?
According to the Drug Manufacturers industry distribution chart, Eton Pharmaceuticals ranks #431 out of 920 companies for Days Inventory. This puts Eton Pharmaceuticals in the upper half of its industry. The industry median Days Inventory is 165.16. Eton Pharmaceuticals' value of 92.22 is 44.2% below this benchmark. Historically, Eton Pharmaceuticals' own Days Inventory has ranged from 25.32 to 678.93 over the past decade. While the company's 10-year median is 150.33 vs. the industry median of 165.16, Eton Pharmaceuticals has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Drug Manufacturers company?
The median Days Inventory among Drug Manufacturers companies is 165.16, based on 920 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eton Pharmaceuticals's current Days Inventory of 92.22 is 44.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Eton Pharmaceuticals and its competitors. For the Drug Manufacturers industry, the median Days Inventory is 165.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eton Pharmaceuticals's current Days Inventory is 92.22, which is 39% below median its own 10-year median of 150.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eton Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, Eton Pharmaceuticals (ETON) is currently considered Significantly Overvalued. The stock's GF Value™ is $19.98, compared to a current price of $58.86 — trading 194.6% above its estimated fair value. The current Days Inventory is 92.22, which is 39% below median its 10-year median of 150.33 and 44.2% below the Drug Manufacturers industry median of 165.16. Eton Pharmaceuticals' overall GF Score™ is 57/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Eton Pharmaceuticals (ETON), the current Days Inventory is 92.22 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eton Pharmaceuticals (ETON) Overvalued in 2026?
Based on GuruFocus' analysis, Eton Pharmaceuticals stock appears to be overvalued.
The current stock price of $58.86 is trading 194.6% above its estimated GF Value™ of $19.98.
GuruFocus considers Eton Pharmaceuticals to be Significantly Overvalued.
Key valuation signals for ETON:
Days Inventory: 92.22 (39% below median its 10-year median of 150.33)
GF Value™: $19.98 vs. price of $58.86 (194.6% above fair value)
Industry Position: 44.2% below the Drug Manufacturers median (#431 of 920)
No single metric tells the full story. See the ETON stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
57GF Score
Get the complete analysis for ETON
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ETON has been successfully added to your 
